Lung Cancer

According to the American Cancer Society, about 14% of all new cancers are lung cancers.

About 2 out of 3 people diagnosed with lung cancer are 65 or older and the average age of diagnosis is 70. 

GoPath has developed several molecular tests to diagnose lung cancer and to detect genetic mutations that are associated with how a cancer progresses. This means that our tests yield results that help your doctor create a treatment plan that's tailor-made to best treat your particular type of lung cancer. 

These tests include:

          •     Driver Profile - Analyzes the following genes for mutations that may affect cancer's progression: EGFR, ALK, ROS1, PDL1
          •     Expanded Driver Profile - EGFR, ALK, ROS1, PDL1, BRAF, MET and RET
          •     EGFR by Peripheral Blood (Liquid Biopsy)
          •     EGFR T790M Drug Resistance (Solid Tumor or Liquid Biopsy)
          •     ALK (FISH) by Peripheral Blood (CTCs)
          •     OncoTargetTM - Detects genetic mutations in a tumor to monitor treatment resistance
          •     Lung Biopsy